Firzacorvir
N/A
Report date: 2023/11/30 17:43:54
NME
Base Information
Drug NameFirzacorvir
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAssembly Biosciences IncIndiana University
China Registration ClassN/A
Develop Information
Active CompaniesBeOne Medicines Ltd
Inactive CompaniesAustarpharma LlcAssembly Biosciences IncAishan Berry Biotechnology (Shanghai) Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A